| scholarly article | Q13442814 |
| P2093 | author name string | J John Mann | |
| Akiva Mintz | |||
| Kiran Kumar Solingapuram Sai | |||
| J S Dileep Kumar | |||
| Jaya Prabhakaran | |||
| Christopher Whitlow | |||
| Gayathri Ramanathan | |||
| Stephanie Rideout | |||
| P2860 | cites work | Neurodegeneration and microtubule dynamics: death by a thousand cuts | Q26781649 |
| Hereditary spastic paraplegia SPG4: what is known and not known about the disease | Q27690406 | ||
| A Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During Disease | Q28079299 | ||
| Autophagy induction stabilizes microtubules and promotes axon regeneration after spinal cord injury | Q30819691 | ||
| An admonition when measuring the lipophilicity of radiotracers using counting techniques | Q31997490 | ||
| The neuronal cytoskeleton in acute brain injury | Q33539694 | ||
| The tubulin code: molecular components, readout mechanisms, and functions | Q34062557 | ||
| Tubulin acetylation: responsible enzymes, biological functions and human diseases | Q34487624 | ||
| Molecules in mammalian brain that interact with the colchicine site on tubulin | Q37320144 | ||
| Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin | Q37570220 | ||
| New drug therapies for multiple sclerosis. | Q37736234 | ||
| Mitochondrial metabolic control of microtubule dynamics impairs the autophagic pathway in Parkinson's disease | Q37966705 | ||
| Microtubule-Targeting Agents Enter the Central Nervous System (CNS): Double-edged Swords for Treating CNS Injury and Disease. | Q38307155 | ||
| Molecular basis of major psychiatric diseases such as schizophrenia and depression | Q38321358 | ||
| The microtubular cytoskeleton of olfactory neurons derived from patients with schizophrenia or with bipolar disorder: Implications for biomarker characterization, neuronal physiology and pharmacological screening. | Q38720037 | ||
| Design, Synthesis, and Preclinical Evaluation of 4-Substituted-5-methyl-furo[2,3-d]pyrimidines as Microtubule Targeting Agents That Are Effective against Multidrug Resistant Cancer Cells | Q38769177 | ||
| The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders | Q38812452 | ||
| Faulty splicing and cytoskeleton abnormalities in Huntington's disease | Q38928751 | ||
| Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells | Q38954268 | ||
| TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells | Q39005489 | ||
| Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs | Q39052949 | ||
| The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy. | Q39149587 | ||
| Microtubule-Based Transport and the Distribution, Tethering, and Organization of Organelles | Q39276510 | ||
| The mechanics of microtubule networks in cell division. | Q39296491 | ||
| A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma | Q46188537 | ||
| Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial | Q48476827 | ||
| Radiosynthesis and in vivo evaluation of [11C]MPC-6827, the first brain penetrant microtubule PET ligand. | Q49849048 | ||
| P433 | issue | 5 | |
| P921 | main subject | radiosynthesis | Q42564982 |
| P304 | page(s) | 452-456 | |
| P577 | publication date | 2018-04-30 | |
| P1433 | published in | ACS Medicinal Chemistry Letters | Q2819061 |
| P1476 | title | Radiosynthesis and Evaluation of [11C]HD-800, a High Affinity Brain Penetrant PET Tracer for Imaging Microtubules | |
| P478 | volume | 9 |
| Q64888589 | Initial biological evaluations of 18F-KS1, a novel ascorbate derivative to image oxidative stress in cancer. | cites work | P2860 |
Search more.